Financial News
Latest News about SNY
Recent news which mentions SNY
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
From InvestorPlace
Why GSK May Have Bet Too Big on a Pandemic Pipeline
May 07, 2022
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
May 06, 2022
From Motley Fool
Why Kymera Therapeutics Shares Are Falling Today
May 03, 2022
From Benzinga
From Motley Fool
From Benzinga
Earnings Scheduled For April 28, 2022
April 28, 2022
From Benzinga
Microsoft Gives Glimpse Of Xbox Cloud Gaming Numbers
April 27, 2022
From Benzinga
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
April 26, 2022
From Benzinga
From Benzinga
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran
April 25, 2022
From Benzinga
Where Will Vertex Pharmaceuticals Be in 5 Years?
April 25, 2022
From Motley Fool
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
April 22, 2022
From Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
From Motley Fool
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
April 14, 2022
Tickers
SNY
From Benzinga
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
Could This Drug Candidate Be a Blockbuster for Sanofi?
April 09, 2022
From Motley Fool
3 Things About Pfizer That Smart Investors Know
April 08, 2022
From Motley Fool
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
From Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
April 07, 2022
From Benzinga
From Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
April 03, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
